Browse > Article
http://dx.doi.org/10.22722/KJPM.2018.26.2.119

Association between Cognitive Function, Behavioral and Psychological Symptoms of Dementia and White Matter Hyperintensities in Patients with Alzheimer's Disease and Mild Cognitive Impairment  

Kwon, Ji Woong (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine)
Kim, Hyun (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine)
Lee, Kang Joon (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine)
Publication Information
Korean Journal of Psychosomatic Medicine / v.26, no.2, 2018 , pp. 119-126 More about this Journal
Abstract
Objectives : The aim of this study is to investigate correlation between degree of white matter hyperintensities (WMH) and neurocognitive function along with behavioral and psychological symptoms of dementia (BPSD) in Korean patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI). Methods : Participants were 115 elderly subjects diagnosed with Alzheimer's disease or mild cognitive impairment in this retrospective study. WMH in brain MRI were rated with standardized visual rating scales (Fazekas scales) and the subjects were divided into two groups according to Fazekas scale. Cognitive function was evaluated with Korean version of the consortium to establish a registry for Alzheimer's Disease (CERAD-K), and BPSD was evaluated with Korean neuropsychiatric inventory (K-NPI). Independent t-test was performed to analyze the relationship between the degree of WMH and neurocognitive functions & BPSD. Results : Especially, the group with high severity of WMH showed significantly lower language fluency (p<0.05). In addition, the group with high severity of WMH showed significantly higher score in K-NPI. Conclusions : There was a significant association between WMH and neurocognitive test related with executive function. Moreover, WMH seems to affect BPSD severity. Evaluation of WMH would provide useful information in clinical settings.
Keywords
Alzheimer's disease; Mild cognitive impairment; White matter hyperintensity; Behavioral Psychological symptoms of dementia (BPSD);
Citations & Related Records
연도 인용수 순위
  • Reference
1 Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage 2011;58:818-828.   DOI
2 Burns JM, Church JA, Johnson DK, Xiong CJ, Marcus D, Fotenos AF, Snyder AZ, Morris JC, Buckner RL. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. Arch Neurol 2005; 62:1870-1876.   DOI
3 Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: A quantitative review. Neuropsychology 2000;14:224-232.   DOI
4 De Groot JC, De Leeuw FE, Oudkerk M, Van Gijn J, Hofman A, Jolles J, Breteler MM. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002;52:335-341.   DOI
5 Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease-the nun study. JAMA 1997;277: 813-817.   DOI
6 Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal P, Oudkerk M, Hofman A, Breteler MM. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004;61: 1531-1534.   DOI
7 Chen TF, Chen YF, Cheng TW, Hua MS, Liu HM, Chiu MJ. Executive Dysfunction and periventricular diffusion tensor changes in amnesic mild cognitive impairment and early Alzheimer's disease. Hum Brain Mapp 2009;30:3826-3836.   DOI
8 Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666.   DOI
9 Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, Erkinjuntti T, Pantoni L, Fazekas F, Visser M, Waldemar G, Wallin A, Hennerici M, Inzitari D. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 2010;75:160-167.   DOI
10 Taylor ME, Lord SR, Delbaere K, Wen W, Jiang J, Brodaty H, Kurrle SE, Stefanie Mikolaizak A, Close JCT. White matter hyperintensities are associated with falls in older people with dementia. Brain Imaging Behav 2018;25:1-8.
11 O'Brien JT. Vascular cognitive impairment. Am J Geriatr Psychiatry 2006;14:724-733.   DOI
12 Jellinger KA. Small concomitant cerebrovascular lesions are not important for cognitive decline in severe Alzheimer disease. Arch Neurol 2001;58:520-521.   DOI
13 Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999;354:919-920.   DOI
14 Kang DW, Lim HK. Current Knowledge and Clinical Application of Brain Imaging in Alzheimer's Disease. J Korean Neuropsychiatr Assoc 2018;57:12-22.   DOI
15 Harper L, Barkhof F, Fox NC, Schott JM. Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. J Neurol Neurosurg Psychiatry 2015;86:1225-1233.   DOI
16 Kwon YC, Park JH. Korean version of Mini-Mental State Examination (MMSE-K) part I: Development of the test for the elderly. J Korean Neuropsychiatr Assoc 1989;28:125-135.
17 Kono I, Mori S, Nakajima K, Nakagawa M, Watanabe Y, Kizu O, Yamada K, Sakai Y. Do white matter changes have clinical significance in Alzheimer's disease? Gerontology 2004; 50:242-246.   DOI
18 Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356.   DOI
19 Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Lee KH. Development of the Korean version of the consortium to establish a registry for alzheimer's disease (CERAD) Assessment packet (CERAD-K): Clinical and Neuropsychological assessment batteries. J Gernotol B Psyhol Sci 2002;57:47-53.   DOI
20 Morris JC. The clinical Dementia rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
21 Piccininni M, Di Carlo A, Baldereschi M, Zaccara G, Inzitari D. Behavioral and psychological symptoms in Alzheimer's disease: frequency and relationship with duration and severity of the disease. Dement Geriatr Cogn Disord 2005;19:276-281.   DOI
22 Gao FQ, Swartz RH, Scheltens P, Leibovitch FS, Kiss A, Honjo K, Black SE. Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study. J Alzheimers Dis 2011;26:379-388.   DOI
23 Reisberg B, Ferris SH, de Leon MJ, Crook T. Global Deterioration scale (GDS). Psychopharmacol Bull 1988;24:661-663.
24 Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory : comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.   DOI
25 Bae JN, Cho MJ. Development of the Korean version of the Geriatric Depression scale and its form among elderly psychiatric patients. J psychosom Res 2004;57:297-305.   DOI
26 Michaela D, Josef M, Eberhard D, Gerog K, Tanja D, Michael S. Impact of White Matter Lesions and Cognitive Deficits on Conversion from Mild Cognitive Impairment to Alzheimer's Disease. Journal of Alzheimer's Disease 2013;34: 665-672.   DOI
27 Ogawa Y, Hashimoto M, Yatabe Y, Kaneda K, Honda K, Yuuki S, Hirai T, Ikeda M. Association of cerebral small vessel disease with delusions in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2013;28:18-25.   DOI
28 Miranda B, Madureira S, Verdelho A, Ferro J, Pantoni L, Salvadori E, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitarion D; LADIS Study. Selfperceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes. J Neurol Neurosurg Psychiatry 2008;79:869-873.   DOI
29 Hart DJ, Craig D, Compton SA, Critchlow S, Kerrigan BM, McIlroy SP, Passmore AP. A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease. Int J Geriatr Psychiatry 2003;18:1037-1042.   DOI
30 Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288:1475-1483.   DOI
31 Berlow YA, Wells WM, Ellison JM, Sung YH, Renshaw PF, Harper DG. Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease. Int J Geriatr Psychiatry 2010;25:780-788.
32 Rosen HJ, Allison SC, Schauer GF, Gorno-Tempini ML, Weiner MW, Miller BL. Neuroanatomical correlates of behavioural disorders in dementia. Brain 2005;128(Pt 11):2612-2625.   DOI
33 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.   DOI
34 Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MW, Chui HC, Jagust WJ. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004;63:246-253.   DOI
35 Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, Hofman A, Breteler MM. Cerebral smallvessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-2041.   DOI
36 Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten EC, van der Flier WM, Barkhof F, Scheltens P, Fazekas F, Schmidt R, Verdelho A, Ferro JM, Pantoni L, Inzitari D, Erkinjuntti T. Incident lacunes influence cognitive decline: the LADIS study. Neurology 2011;76:1872-1878.   DOI
37 de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology 2001;56:1539-1545.   DOI
38 Choi L, Joo SH, Lee CU, Paik IH. Association between Global Cortical Atrophy, Medial Temporal Atrophy, White Matter Hyperintensities and Cognitive Functions in Korean Alzheimer's Disease Patients. Korean J Biol Psychiatry 2015;22:140-148
39 Duffy JD, Campbell JJ 3rd. The regional prefrontal syndromes: a theoretical and clinical overview. J Neuropsychiatry Clin Neurosci 1994;6:379-387.   DOI
40 Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, De-Carli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240-246.   DOI
41 Starkstein SE, Sabe L, Vazquez S, Di Lorenzo G, Martinez A, Petracca G, Teson A, Chemerinski E, Leiguarda R. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1997;63:66-73.   DOI
42 Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53:647-654.   DOI
43 Nagaendran K, Russel C, Angeline Z, Cheong CY. Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease. Journal of the Neurological Sciences 2014;337:162-166.   DOI
44 Clark LM, McDonald WM, Welsh-Bohmer KA, Siegler IC, Dawson DV, Tupler LA, Krishnan KR. Magnetic resonance imaging correlates of depression in early- and late-onset Alzheimer's disease. Biol Psychiatry 1998;44:592-599.   DOI
45 Harrell LE, Duvall E, Folks DG, Duke L, Bartolucci A, Conboy T, Callaway R, Kerns D. The relationship of high-intensity signals on magnetic resonance images to cognitive and psychiatric state in Alzheimer's disease. Arch Neurol 1991;48: 1136-1140.   DOI
46 Son SJ, Lee KS, lee YH, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH. Assoication between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ${\varepsilon}4$ allele in the elderly: retrospective analysis of data from the CREDOS study. (2015). J Clin Psychiatry 2012;73:1555-1562.   DOI
47 Treiber KA, Lyketsos CG, Corcoran C, Steinberg M, Norton M, Green RC, Rabins P, Stein DM, Welsh-Bohmer KA, Breitner JC, Tschanz JT. Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. Int Psychogeriatr 2008;20:538-553.
48 Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Alzheimer Dis Assoc Disord 1988;2:134.
49 Park YS, Suk MS. The improvement plan of social welfare service for advancing family resilience of caring dementias. J Korean Soc Welf Adm 2002;6:119-144.
50 Kim JM, Shin IS, Yoon JS. Determinants of care burden of caregiver inpatients with dementia. J Korean Neuropsychiatr Assoc 2001;40:1006-1013.